Cargando…
4164 Body mass index, not chemotherapy is the major predictor of insulin resistance in patients with hematological malignancies
OBJECTIVES/GOALS: Cancer survivors are at increased risk for type 2 diabetes mellitus.It is not clear if diabetes susceptibility is due to shared risk factors for cancer and diabetes, such as obesity, or if it is directly related to cancer and its treatment. We investigated the association between m...
Autores principales: | Sahinoz, Melis, Engelhardt, Brian, Jung, Dae Kwang, Luther, James Matthew, Ikizler, Talat Alp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823689/ http://dx.doi.org/10.1017/cts.2020.372 |
Ejemplares similares
-
Hematologic malignancies magnify the effect of body mass index on insulin resistance in cancer survivors
por: Sahinoz, Melis, et al.
Publicado: (2022) -
59473 Clinical and demographic predictors of the need for pharmacotherapy in Neonatal Abstinence Syndrome (NAS)
por: Bibi, Shawana, et al.
Publicado: (2021) -
3251 Psoas muscle caliber as a predictor of negative outcomes in elderly trauma patients
por: Meader, Anna, et al.
Publicado: (2019) -
3451 Pain, Quality of Life, and Emotional Measures as Predictors for Outcomes following Surgery for Nerve Injuries
por: Heary, Kartemus, et al.
Publicado: (2019) -
42956 Patterns and impact of long-term glucocorticoid use on RA patients at risk for major adverse cardiac events
por: Wallace, Beth I., et al.
Publicado: (2021)